6.3.2 Glucocorticoid therapy

Dexamethasone
Dexamethasone (base) 3.3mg/1ml solution for injection ampoules

On formulary for the treatment of:

Therapeutic Area Condition
Endocrine system Corticosteroids – general use
Dexamethasone 2mg tablets

On formulary for the treatment of:

Therapeutic Area Condition
Endocrine system Corticosteroids – general use
Dexamethasone 500microgram tablets

On formulary for the treatment of:

Therapeutic Area Condition
Endocrine system Corticosteroids – general use
Hydrocortisone
Hydrocortisone 10mg tablets

On formulary for the treatment of:

Therapeutic Area Condition
Endocrine system Primary adrenal insufficiency (Addison’s disease)
Endocrine system Corticosteroids – general use
Hydrocortisone 20mg tablets

On formulary for the treatment of:

Therapeutic Area Condition
Endocrine system Primary adrenal insufficiency (Addison’s disease)
Endocrine system Corticosteroids – general use
Hydrocortisone sodium succinate 100mg powder and solvent for solution for injection vials

On formulary for the treatment of:

Therapeutic Area Condition
Endocrine system Corticosteroids – general use
Endocrine system Primary adrenal insufficiency (Addison’s disease)
Hydrocortisone sodium succinate 100mg powder for solution for injection vials

On formulary for the treatment of:

Therapeutic Area Condition
Endocrine system Corticosteroids – general use
Endocrine system Primary adrenal insufficiency (Addison’s disease)
Methylprednisolone acetate
Methylprednisolone acetate 120mg/3ml suspension for injection vials

On formulary for the treatment of:

Therapeutic Area Condition
Endocrine system Corticosteroids – general use
Methylprednisolone acetate 40mg/1ml suspension for injection vials

On formulary for the treatment of:

Therapeutic Area Condition
Endocrine system Corticosteroids – general use
Methylprednisolone acetate 80mg/2ml suspension for injection vials

On formulary for the treatment of:

Therapeutic Area Condition
Endocrine system Corticosteroids – general use
Methylprednisolone sodium succinate
Methylprednisolone sodium succinate 125mg powder and solvent for solution for injection vials

On formulary for the treatment of:

Therapeutic Area Condition
Endocrine system Corticosteroids – general use
Methylprednisolone sodium succinate 1g powder and solvent for solution for injection vials

On formulary for the treatment of:

Therapeutic Area Condition
Endocrine system Corticosteroids – general use
Methylprednisolone sodium succinate 40mg powder and solvent for solution for injection vials

On formulary for the treatment of:

Therapeutic Area Condition
Endocrine system Corticosteroids – general use
Methylprednisolone sodium succinate 500mg powder and solvent for solution for injection vials

On formulary for the treatment of:

Therapeutic Area Condition
Endocrine system Corticosteroids – general use
Solu-Medrone 125mg powder and solvent for solution for injection vials

On formulary for the treatment of:

Therapeutic Area Condition
Skin Autoimmune bullous dermatoses
Solu-Medrone 1g powder and solvent for solution for injection vials

On formulary for the treatment of:

Therapeutic Area Condition
Skin Autoimmune bullous dermatoses
Solu-Medrone 40mg powder and solvent for solution for injection vials

On formulary for the treatment of:

Therapeutic Area Condition
Skin Autoimmune bullous dermatoses
Solu-Medrone 500mg powder and solvent for solution for injection vials

On formulary for the treatment of:

Therapeutic Area Condition
Skin Autoimmune bullous dermatoses
Prednisolone
Prednisolone 1mg tablets

On formulary for the treatment of:

Therapeutic Area Condition
Endocrine system Corticosteroids – general use
Prednisolone 5mg tablets

On formulary for the treatment of:

Therapeutic Area Condition
Endocrine system Corticosteroids – general use
Respiratory system Chronic Obstructive Pulmonary Disease (COPD)
Skin Autoimmune bullous dermatoses